Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation.
Epperla N, Huang Y, Cashen AF, Vaughn JL, Hanel W, Badar T, Barta SK, Caimi PF, Sethi TK, Reddy N, Karmali R, Bello C, Chavez JC, Kothari SK, Hernandez-Ilizaliturri FJ, Svoboda J, Lansigan F, Glenn MJ, Cohen JB, Sorge C, Christian B, Herrera AF, Hamadani M, Costa LJ, Xavier AC.
Epperla N, et al. Among authors: xavier ac.
Blood Adv. 2024 Nov 12;8(21):5458-5466. doi: 10.1182/bloodadvances.2024013743.
Blood Adv. 2024.
PMID: 39213424
Free PMC article.